146 related articles for article (PubMed ID: 16361923)
1. The use of recombinant activated factor VII in trauma-associated hemorrhage with crush injury.
Christians K; Brasel K; Garlitz J; Abu-Hajir M; Gottschall J
J Trauma; 2005 Sep; 59(3):742-6. PubMed ID: 16361923
[No Abstract] [Full Text] [Related]
2. Case scenario: management of trauma-induced coagulopathy in a severe blunt trauma patient.
David JS; Godier A; Dargaud Y; Inaba K
Anesthesiology; 2013 Jul; 119(1):191-200. PubMed ID: 23514719
[No Abstract] [Full Text] [Related]
3. Low-dose recombinant activated factor VII in massively transfused trauma patients with coagulopathy.
Bauzá G; Hirsch E; Burke P; Quillen K
Transfusion; 2007 Apr; 47(4):749-51. PubMed ID: 17381636
[No Abstract] [Full Text] [Related]
4. Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.
Hauser CJ; Boffard K; Dutton R; Bernard GR; Croce MA; Holcomb JB; Leppaniemi A; Parr M; Vincent JL; Tortella BJ; Dimsits J; Bouillon B;
J Trauma; 2010 Sep; 69(3):489-500. PubMed ID: 20838118
[TBL] [Abstract][Full Text] [Related]
5. [Recombinant activated Factor VII (Novo Seven) for uncontrollable hemorrhage in critically ill patients with multiple injuries].
Pernazza F; Olearis A
Minerva Chir; 2004 Apr; 59(2):XVII-XIX. PubMed ID: 15455479
[No Abstract] [Full Text] [Related]
6. Current world literature. Trauma and transfusion.
Curr Opin Anaesthesiol; 2009 Apr; 22(2):321-5. PubMed ID: 19399963
[No Abstract] [Full Text] [Related]
7. Treatment of an acquired coagulopathy with recombinant activated factor VII in a damage-control patient.
Holcomb JB; Hoots K; Moore FA
Mil Med; 2005 Apr; 170(4):287-90. PubMed ID: 15916295
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Factor VIIa in blunt pelvic trauma.
Hurst T; Blanckley S; Forrest M
Anaesthesia; 2005 Dec; 60(12):1244-5; author reply 1245. PubMed ID: 16288629
[No Abstract] [Full Text] [Related]
9. Use of recombinant factor VIIa for major haemorrhage.
Pugh RJ; Wenstone R; Martlew VJ; Marx G
Eur J Anaesthesiol; 2005 Jul; 22(7):548-50. PubMed ID: 16045146
[No Abstract] [Full Text] [Related]
10. Management of acquired bleeding problems in cancer patients.
DeLoughery TG
Emerg Med Clin North Am; 2009 Aug; 27(3):423-44. PubMed ID: 19646646
[TBL] [Abstract][Full Text] [Related]
11. Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial.
Kluger Y; Riou B; Rossaint R; Rizoli SB; Boffard KD; Choong PI; Warren B; Tillinger M
Crit Care; 2007; 11(4):R85. PubMed ID: 17686152
[TBL] [Abstract][Full Text] [Related]
12. [Recombinant activated factor VIIa for treatment of traumatic liver rupture].
Leidinger W; Meierhofer JN; Woelfel R
Anaesthesist; 2006 Aug; 55(8):868-72. PubMed ID: 16649014
[TBL] [Abstract][Full Text] [Related]
13. Effects of recombinant activated factor VII in traumatic nonsurgical intracranial hemorrhage.
White CE; Schrank AE; Baskin TW; Holcomb JB
Curr Surg; 2006; 63(5):310-7. PubMed ID: 16971200
[TBL] [Abstract][Full Text] [Related]
14. The role of recombinant factor VIIa in the treatment of life-threatening haemorrhage in blunt trauma.
Geeraedts LM; Kamphuisen PW; Kaasjager HA; Verwiel JM; van Vugt AB; Frölke JP
Injury; 2005 Apr; 36(4):495-500. PubMed ID: 15755430
[TBL] [Abstract][Full Text] [Related]
15. Blood component supplementation during massive transfusion of AS-1 red cells in trauma patients.
Faringer PD; Mullins RJ; Johnson RL; Trunkey DD
J Trauma; 1993 Apr; 34(4):481-5; discussion 485-7. PubMed ID: 8487331
[TBL] [Abstract][Full Text] [Related]
16. Open pelvic fractures: experience with recombinant factor VIIa, degloving and bowel injury.
Overdevest GM; Heetveld MJ
Injury; 2007 Mar; 38(3):384-91. PubMed ID: 17296197
[No Abstract] [Full Text] [Related]
17. [Coagulation management in major trauma].
Schöchl H
Hamostaseologie; 2006 Aug; 26(3 Suppl 1):S52-5. PubMed ID: 16953293
[TBL] [Abstract][Full Text] [Related]
18. A response to 'the use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
Geoghegan J; Tasker L
Anaesthesia; 2005 Nov; 60(11):1156-7; author reply 1157. PubMed ID: 16229713
[No Abstract] [Full Text] [Related]
19. [Activated recombinant factor VII (Novoseven) in multiple trauma patients: an outcome analysis].
Grinţescu I; Tulbure D; Mirea L
Chirurgia (Bucur); 2006; 101(6):615-24. PubMed ID: 17283837
[TBL] [Abstract][Full Text] [Related]
20. The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
Udy A; Vaghela M; Lawton G; Sigston P
Anaesthesia; 2005 Jun; 60(6):613-6. PubMed ID: 15918835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
